Diclofenac epolamine

双氯芬酸依泊胺

Report date: 2025/05/21 20:00:31
NME

Base Information

Drug NameDiclofenac epolamine
Drug Alias NameDiclofenac hydroxyethylpyrrolidine双氯芬酸环磷胺FlectorLicart
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsCyclooxygenase-1 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsSoft Tissue InjuriesAcute PainPain
Global Approved IndicationsAcute PainPain
Approved Indications in ChinaN/A
Original Approved Country/TerritorySwitzerland
Original Approved Date1993/01/01
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIbsa Institut Biochimique Sa
China Registration ClassN/A

Develop Information

Active CompaniesAltasciences Company IncIbsa Institut Biochimique SaInstitute Of Biochemistry
Inactive CompaniesN/A
Active IndicationsSoft Tissue InjuriesAcute PainPain
Inactive IndicationsN/A

Other Information

ATC CodeM02AB
Related LinksWikipediaDrugBankKEGG